These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26035559)

  • 1. [Genetic engineering technologies of stimulating angiogenesis as an innovation trend in angiology and vascular surgery].
    Gavrilenko AV; Voronov DA
    Angiol Sosud Khir; 2015; 21(2):7-10, 12-4. PubMed ID: 26035559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 1)].
    Gavrilenko AV; Voronov DA
    Angiol Sosud Khir; 2015; 21(3):7-15. PubMed ID: 26355918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The opportunities for genic therapy of chronic obliterating diseases of lower limbs arteries].
    Cherviakov IuA; Staroverov IN; Nersesian EG; Vlasenko ON; Isaev AA; Deev RV
    Khirurgiia (Mosk); 2014; (4):40-5. PubMed ID: 24816386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination of reconstructive vascular operations with gene-engineering technologies of angiogenesis stimulation: a present-day policy aimed at improving the remote results of treating patients with lower limb chronic ischaemia].
    Gavrilenko AV; Voronov DA; Konstantinov BA; Bochkov NP
    Angiol Sosud Khir; 2008; 14(4):49-53. PubMed ID: 19791552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 2)].
    Gavrilenko AV; Voronov DA
    Angiol Sosud Khir; 2015; 21(4):29-35. PubMed ID: 26673292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
    Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
    J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic cellular angiogenesis in treatment of peripheral artery diseases].
    Khorev NG; Elykomov VA; Zaloznyĭ DA
    Angiol Sosud Khir; 2011; 17(2):36-44. PubMed ID: 21983460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Worldwide experience and recent trends in gene therapy of ischaemic diseases].
    Deev RV; Grigorian AS; Potapov IV; Kiselev SL; Isaev AA
    Angiol Sosud Khir; 2011; 17(2):145-54. PubMed ID: 21998874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of using VEGF165 gene in comprehensive treatment of patients with stage 2A-3 lower limb chronic ischaemia].
    Deev RV; Bozo IIa; Mzhavanadze ND; Nersesian EG; Chukhralia OV; Shval'b PG; Cherviakov IuV; Staroverov IN; Kalinin RE; Voronov DA; Gavrilenko AV; Isaev AA
    Angiol Sosud Khir; 2014; 20(2):38-48. PubMed ID: 24961325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in vascular disease.
    Sedighiani F; Nikol S
    Surgeon; 2011 Dec; 9(6):326-35. PubMed ID: 22041646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beperminogene perplasmid for the treatment of critical limb ischemia.
    Suda H; Murakami A; Kaga T; Tomioka H; Morishita R
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1145-56. PubMed ID: 25190335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of genetic angiogenesis inductors in surgical treatment of chronic lower limb ischemia].
    Gavrilenko AV; Voronov DA; Bochkov NP
    Khirurgiia (Mosk); 2013; (2):25-9. PubMed ID: 23503379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis. Devising new strategies based on past experiences.
    Lei Y; Haider HKh; Shujia J; Sim ES
    Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcomes of using autologous peripheral-blood stem cells in patients with chronic lower arterial insufficiency].
    Maksimov AV; Kiiasov AP; Plotnikov MV; Maianskaia SD; Shamsutdinova II; Gazizov IM; Mavlikeev MO
    Angiol Sosud Khir; 2011; 17(2):11-5. PubMed ID: 21983456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic angiogenesis for ischemic diseases].
    Aoki M; Morishita R
    Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and gene therapy in man: dream or reality?
    Amant C; Berthou L; Walsh K
    Drugs; 1999; 58 Spec No 1():33-6. PubMed ID: 10526956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for peripheral artery disease: stem cell therapy.
    Lachmann N; Nikol S
    Vasa; 2007 Nov; 36(4):241-51. PubMed ID: 18357916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 levels and activity decrease after intervention in patients with critical limb ischaemia.
    Björck M; Lepkowska Eriksson M; Bylock A; Steuer J; Wanhainen A; Carlsson BC; Bock D; Kragsterman B
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):214-22. PubMed ID: 23770264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.